Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000660041 | SCV000781993 | uncertain significance | Neurofibromatosis, type 1 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000660041 | SCV004297472 | pathogenic | Neurofibromatosis, type 1 | 2023-03-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NF1 protein in which other variant(s) (p.Gly1219Val) have been determined to be pathogenic (PMID: 31573083; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 547632). This variant is also known as c.3654_3656delAGG. This variant has been observed in individual(s) with neurofibromatosis, type 1 (PMID: 25074460). This variant is not present in population databases (gnomAD no frequency). This variant, c.3656_3658del, results in the deletion of 1 amino acid(s) of the NF1 protein (p.Gly1219del), but otherwise preserves the integrity of the reading frame. |